Barclays Maintains Equal-Weight on Phreesia, Raises Price Target to $11
Barclays analyst Glen Santangelo maintains Phreesia (NYSE:PHR) with a Equal-Weight and raises the price target from $10 to $11.
Stocks · News reference
Needham Reiterates Buy on Phreesia, Maintains $14 Price Target
Needham analyst Ryan MacDonald reiterates Phreesia (NYSE:PHR) with a Buy and maintains $14 price target.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures fell, with Dow futures down 450 points. Argenx sank 8.7% after a Sjögren’s trial was halted for futility; others also slid.
Raymond James Downgrades Phreesia to Market Perform
DA Davidson Maintains Buy on Phreesia, Lowers Price Target to $13